Michel Vounatsos
2016
In 2016, Michel Vounatsos earned a total compensation of $5.8M as Chief Executive Officer at Biogen.
Compensation breakdown
| Bonus | $1,500,000 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,598 |
| Non-Equity Incentive Plan | $447,799 |
| Salary | $519,231 |
| Stock Awards | $3,151,199 |
| Other | $181,568 |
| Total | $5,801,395 |
Vounatsos received $3.2M in stock awards, accounting for 54% of the total pay in 2016.
Vounatsos also received $1.5M in bonus, $1.6K of change in pension value and nonqualified deferred compensation earnings, $447.8K in non-equity incentive plan, $519.2K in salary and $181.6K in other compensation.
Rankings
In 2016, Michel Vounatsos' compensation ranked 1,282nd out of 14,075 executives tracked by ExecPay. In other words, Vounatsos earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,282 out of 14,075 | 91st |
Division Manufacturing | 429 out of 5,489 | 92nd |
Major group Chemicals And Allied Products | 112 out of 1,895 | 94th |
Industry group Drugs | 74 out of 1,538 | 95th |
Industry Biological Products, Except Diagnostic Substances | 14 out of 279 | 95th |
Source: SEC filing on April 27, 2018.
Vounatsos' colleagues
We found five more compensation records of executives who worked with Michel Vounatsos at Biogen in 2016.
2016
George Scangos
Biogen
Chief Executive Officer
2016
Michael Ehlers
Biogen
Executive Vice President, Research & Development
2016
Paul Clancy
Biogen
Chief Financial Officer
2016
Kenneth DiPietro
Biogen
Former Executive Vice President, Human Resources
2016
Susan Alexander
Biogen